J2407 Injection, oritavancin (orbactiv), 10 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Injection, oritavancin
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, oritavancin (orbactiv), 10 mg | yes |
Related codes in J24
- J2401 Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404 Injection, nicardipine, 0.1 mg
- J2405 Injection, ondansetron hydrochloride, per 1 mg
- J2406 Injection, oritavancin (kimyrsa), 10 mg
- J2410 Injection, oxymorphone hcl, up to 1 mg
- J2425 Injection, palifermin, 50 micrograms
- J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428 Injection, paliperidone palmitate extended release (erzofri), 1 mg
- J2430 Injection, pamidronate disodium, per 30 mg
- J2440 Injection, papaverine hcl, up to 60 mg
- J2460 Injection, oxytetracycline hcl, up to 50 mg
- J2468 Injection, palonosetron hydrochloride (posfrea), 25 micrograms
- J2469 Injection, palonosetron hcl, 25 mcg
- J2470 Injection, pantoprazole sodium, 40 mg
- J2471 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
- J2472 Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg